Sarepta Therapeutics, Inc. (SRPT)
NASDAQ: SRPT · Real-Time Price · USD
16.01
-0.67 (-4.02%)
At close: Nov 12, 2026, 4:00 PM EST
16.14
+0.13 (0.81%)
After-hours: Nov 12, 2026, 7:30 PM EST
Sarepta Therapeutics Stock Forecast
Stock Price Forecast
According to 24 analysts polled by S&P Global, Sarepta Therapeutics stock has a consensus rating of "Hold" and an average price target of $21.77. The average 1-year stock price forecast is 35.98% higher than the current stock price, while the lowest is $5.00 (-68.77%) and the highest is $38 (+137.35%).
Price Target: $21.77 (+35.98%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Sarepta Therapeutics stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 8 | 8 | 7 | 7 | 7 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 13 | 11 | 11 | 12 | 12 | 13 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 3 | 3 | 3 | 3 | 3 | 2 |
| Total | 25 | 24 | 24 | 24 | 24 | 24 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Hold Upgrades $18 | Hold | Upgrades | $18 | +12.43% | Nov 10, 2026 |
| Citi | Citi | Sell Reiterates $13 | Sell | Reiterates | $13 | -18.80% | Nov 9, 2026 |
| Barclays | Barclays | Hold Maintains $20 | Hold | Maintains | $20 | +24.92% | Nov 9, 2026 |
| Bank of America Securities | Bank of America Securities | Sell Maintains n/a | Sell | Maintains | n/a | n/a | Nov 7, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Reiterates $25 | Hold | Reiterates | $25 | +56.15% | Nov 6, 2026 |
Financial Forecast
Revenue This Year
1.86B
from 2.20B
Decreased by -15.28%
Revenue Next Year
1.38B
from 1.86B
Decreased by -25.68%
EPS This Year
3.95
from -5.05
EPS Next Year
1.48
from 3.95
Decreased by -62.48%
EPS and Forward PE are based on non-GAAP adjusted numbers.